From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer
Risk of
Time after treatment
HR
95%CI
P
Recurrence
3 months
1.083
1.05–1.12
< 0.0001
6 months
1.018
1.01–1.03
Death
1.08
1.03–1.13
0.0007
1.02
0.0001